Global Hemophilia A Drug Market Research Report 2017

December 2017 | 117 pages | ID: GE38A6AE43CEN
QYResearch

Abstracts

In this report, the global Hemophilia A Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hemophilia A Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Hemophilia A Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Bayer AG
• BioMarin Pharmaceutical Inc
• Bioverativ Inc
• Catalyst Biosciences Inc
• Chugai Pharmaceutical Co Ltd
• CSL Ltd
• DBV Technologies SA
• Dimension Therapeutics Inc
• EpiVax Inc
• Expression Therapeutics LLC
• Green Cross Corp
• Idogen AB
• Immusoft Corp
• LFB SA
• mAbxience SA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ATXF-8117
• BAY-1093884
• BIVV-001
• BS-027125
• Concizumab
• CSL-689
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Clinic
• Hospital
• ASCs

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hemophilia A Drug Market Research Report 2017

1 HEMOPHILIA A DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Hemophilia A Drug
1.2 Hemophilia A Drug Segment by Type (Product Category)
  1.2.1 Global Hemophilia A Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Hemophilia A Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 ATXF-8117
  1.2.4 BAY-1093884
  1.2.5 BIVV-001
  1.2.6 BS-027125
  1.2.7 Concizumab
  1.2.8 CSL-689
  1.2.9 Others
1.3 Global Hemophilia A Drug Segment by Application
  1.3.1 Hemophilia A Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 ASCs
1.4 Global Hemophilia A Drug Market by Region (2012-2022)
  1.4.1 Global Hemophilia A Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Hemophilia A Drug (2012-2022)
  1.5.1 Global Hemophilia A Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Hemophilia A Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL HEMOPHILIA A DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Hemophilia A Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Hemophilia A Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Hemophilia A Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Hemophilia A Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Hemophilia A Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Hemophilia A Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hemophilia A Drug Market Competitive Situation and Trends
  2.5.1 Hemophilia A Drug Market Concentration Rate
  2.5.2 Hemophilia A Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL HEMOPHILIA A DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Hemophilia A Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Hemophilia A Drug Production and Market Share by Region (2012-2017)
3.3 Global Hemophilia A Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL HEMOPHILIA A DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Hemophilia A Drug Consumption by Region (2012-2017)
4.2 North America Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL HEMOPHILIA A DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Hemophilia A Drug Production and Market Share by Type (2012-2017)
5.2 Global Hemophilia A Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Hemophilia A Drug Price by Type (2012-2017)
5.4 Global Hemophilia A Drug Production Growth by Type (2012-2017)

6 GLOBAL HEMOPHILIA A DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Hemophilia A Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Hemophilia A Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL HEMOPHILIA A DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Bayer AG
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Hemophilia A Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Bayer AG Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 BioMarin Pharmaceutical Inc
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Hemophilia A Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Bioverativ Inc
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Hemophilia A Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Bioverativ Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Catalyst Biosciences Inc
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Hemophilia A Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Catalyst Biosciences Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Chugai Pharmaceutical Co Ltd
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Hemophilia A Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 CSL Ltd
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Hemophilia A Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 CSL Ltd Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 DBV Technologies SA
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Hemophilia A Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 DBV Technologies SA Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Dimension Therapeutics Inc
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Hemophilia A Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Dimension Therapeutics Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 EpiVax Inc
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Hemophilia A Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 EpiVax Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Expression Therapeutics LLC
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Hemophilia A Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Expression Therapeutics LLC Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Green Cross Corp
7.12 Idogen AB
7.13 Immusoft Corp
7.14 LFB SA
7.15 mAbxience SA

8 HEMOPHILIA A DRUG MANUFACTURING COST ANALYSIS

8.1 Hemophilia A Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hemophilia A Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Hemophilia A Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemophilia A Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL HEMOPHILIA A DRUG MARKET FORECAST (2017-2022)

12.1 Global Hemophilia A Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Hemophilia A Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Hemophilia A Drug Price and Trend Forecast (2017-2022)
12.2 Global Hemophilia A Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Hemophilia A Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Hemophilia A Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia A Drug
Figure Global Hemophilia A Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Hemophilia A Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of ATXF-8117
Table Major Manufacturers of ATXF-8117
Figure Product Picture of BAY-1093884
Table Major Manufacturers of BAY-1093884
Figure Product Picture of BIVV-001
Table Major Manufacturers of BIVV-001
Figure Product Picture of BS-027125
Table Major Manufacturers of BS-027125
Figure Product Picture of Concizumab
Table Major Manufacturers of Concizumab
Figure Product Picture of CSL-689
Table Major Manufacturers of CSL-689
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Hemophilia A Drug Consumption (K Pcs) by Applications (2012-2022)
Figure Global Hemophilia A Drug Consumption Market Share by Applications in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure ASCs Examples
Table Key Downstream Customer in ASCs
Figure Global Hemophilia A Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Hemophilia A Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Hemophilia A Drug Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Hemophilia A Drug Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Hemophilia A Drug Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Hemophilia A Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Hemophilia A Drug Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Hemophilia A Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Hemophilia A Drug Major Players Product Production (K Pcs) (2012-2017)
Table Global Hemophilia A Drug Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Hemophilia A Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Hemophilia A Drug Production Share by Manufacturers
Figure 2017 Hemophilia A Drug Production Share by Manufacturers
Figure Global Hemophilia A Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Hemophilia A Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Hemophilia A Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Hemophilia A Drug Revenue Share by Manufacturers
Table 2017 Global Hemophilia A Drug Revenue Share by Manufacturers
Table Global Market Hemophilia A Drug Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Hemophilia A Drug Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Hemophilia A Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Hemophilia A Drug Product Category
Figure Hemophilia A Drug Market Share of Top 3 Manufacturers
Figure Hemophilia A Drug Market Share of Top 5 Manufacturers
Table Global Hemophilia A Drug Capacity (K Pcs) by Region (2012-2017)
Figure Global Hemophilia A Drug Capacity Market Share by Region (2012-2017)
Figure Global Hemophilia A Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Hemophilia A Drug Capacity Market Share by Region
Table Global Hemophilia A Drug Production by Region (2012-2017)
Figure Global Hemophilia A Drug Production (K Pcs) by Region (2012-2017)
Figure Global Hemophilia A Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Hemophilia A Drug Production Market Share by Region
Table Global Hemophilia A Drug Revenue (Million USD) by Region (2012-2017)
Table Global Hemophilia A Drug Revenue Market Share by Region (2012-2017)
Figure Global Hemophilia A Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Hemophilia A Drug Revenue Market Share by Region
Figure Global Hemophilia A Drug Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Hemophilia A Drug Consumption (K Pcs) Market by Region (2012-2017)
Table Global Hemophilia A Drug Consumption Market Share by Region (2012-2017)
Figure Global Hemophilia A Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Hemophilia A Drug Consumption (K Pcs) Market Share by Region
Table North America Hemophilia A Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Hemophilia A Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Hemophilia A Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Hemophilia A Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Hemophilia A Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Hemophilia A Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Hemophilia A Drug Production (K Pcs) by Type (2012-2017)
Table Global Hemophilia A Drug Production Share by Type (2012-2017)
Figure Production Market Share of Hemophilia A Drug by Type (2012-2017)
Figure 2016 Production Market Share of Hemophilia A Drug by Type
Table Global Hemophilia A Drug Revenue (Million USD) by Type (2012-2017)
Table Global Hemophilia A Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Hemophilia A Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Hemophilia A Drug by Type
Table Global Hemophilia A Drug Price (USD/Pcs) by Type (2012-2017)
Figure Global Hemophilia A Drug Production Growth by Type (2012-2017)
Table Global Hemophilia A Drug Consumption (K Pcs) by Application (2012-2017)
Table Global Hemophilia A Drug Consumption Market Share by Application (2012-2017)
Figure Global Hemophilia A Drug Consumption Market Share by Applications (2012-2017)
Figure Global Hemophilia A Drug Consumption Market Share by Application in 2016
Table Global Hemophilia A Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Hemophilia A Drug Consumption Growth Rate by Application (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Hemophilia A Drug Production Growth Rate (2012-2017)
Figure Bayer AG Hemophilia A Drug Production Market Share (2012-2017)
Figure Bayer AG Hemophilia A Drug Revenue Market Share (2012-2017)
Table BioMarin Pharmaceutical Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Production Growth Rate (2012-2017)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Production Market Share (2012-2017)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Revenue Market Share (2012-2017)
Table Bioverativ Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bioverativ Inc Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bioverativ Inc Hemophilia A Drug Production Growth Rate (2012-2017)
Figure Bioverativ Inc Hemophilia A Drug Production Market Share (2012-2017)
Figure Bioverativ Inc Hemophilia A Drug Revenue Market Share (2012-2017)
Table Catalyst Biosciences Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Catalyst Biosciences Inc Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Catalyst Biosciences Inc Hemophilia A Drug Production Growth Rate (2012-2017)
Figure Catalyst Biosciences Inc Hemophilia A Drug Production Market Share (2012-2017)
Figure Catalyst Biosciences Inc Hemophilia A Drug Revenue Market Share (2012-2017)
Table Chugai Pharmaceutical Co Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Growth Rate (2012-2017)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Market Share (2012-2017)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Revenue Market Share (2012-2017)
Table CSL Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Ltd Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Ltd Hemophilia A Drug Production Growth Rate (2012-2017)
Figure CSL Ltd Hemophilia A Drug Production Market Share (2012-2017)
Figure CSL Ltd Hemophilia A Drug Revenue Market Share (2012-2017)
Table DBV Technologies SA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DBV Technologies SA Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure DBV Technologies SA Hemophilia A Drug Production Growth Rate (2012-2017)
Figure DBV Technologies SA Hemophilia A Drug Production Market Share (2012-2017)
Figure DBV Technologies SA Hemophilia A Drug Revenue Market Share (2012-2017)
Table Dimension Therapeutics Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dimension Therapeutics Inc Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dimension Therapeutics Inc Hemophilia A Drug Production Growth Rate (2012-2017)
Figure Dimension Therapeutics Inc Hemophilia A Drug Production Market Share (2012-2017)
Figure Dimension Therapeutics Inc Hemophilia A Drug Revenue Market Share (2012-2017)
Table EpiVax Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EpiVax Inc Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure EpiVax Inc Hemophilia A Drug Production Growth Rate (2012-2017)
Figure EpiVax Inc Hemophilia A Drug Production Market Share (2012-2017)
Figure EpiVax Inc Hemophilia A Drug Revenue Market Share (2012-2017)
Table Expression Therapeutics LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Expression Therapeutics LLC Hemophilia A Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Expression Therapeutics LLC Hemophilia A Drug Production Growth Rate (2012-2017)
Figure Expression Therapeutics LLC Hemophilia A Drug Production Market Share (2012-2017)
Figure Expression Therapeutics LLC Hemophilia A Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia A Drug
Figure Manufacturing Process Analysis of Hemophilia A Drug
Figure Hemophilia A Drug Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia A Drug Major Manufacturers in 2016
Table Major Buyers of Hemophilia A Drug
Table Distributors/Traders List
Figure Global Hemophilia A Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hemophilia A Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Hemophilia A Drug Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Hemophilia A Drug Production Market Share Forecast by Region (2017-2022)
Table Global Hemophilia A Drug Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Hemophilia A Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Hemophilia A Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Hemophilia A Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Hemophilia A Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Hemophilia A Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Hemophilia A Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Hemophilia A Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Hemophilia A Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Hemophilia A Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Hemophilia A Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Hemophilia A Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Hemophilia A Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Hemophilia A Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Hemophilia A Drug Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Hemophilia A Drug Production (K Pcs) Forecast by Type (2017-2022)
Table Global Hemophilia A Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Hemophilia A Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Hemophilia A Drug Price Forecast by Type (2017-2022)
Table Global Hemophilia A Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Hemophilia A Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source